Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Managing Alzheimer's disease: global care and support program].

Fati Nourhashémi1, Sophie Gillette, Sandrine Andrieu

  • 1Hôpitaux de Toulouse (P. B. Vellas), 31300 Toulouse. nourhashemi.f@chu-toulouse.fr

La Revue Du Praticien
|January 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Provider and patient perspectives on the diagnosis and treatment of Alzheimer's disease: A global perspective from the Global Alzheimer's Leadership Series (GoALS).

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Feeling Younger as an Indicator of Better Overall Intrinsic Capacities in the INSPIRE-T Cohort.

International journal of geriatric psychiatry·2026
Same author

Bidirectional associations between biological aging, cardiovascular health, and cardiovascular risk: findings from the INSPIRE-T lifespan cohort.

GeroScience·2026
Same author

Meta-Analysis and Bioinformatic Analysis of Human Fluid Proteomic Studies Reveal Key Biological Pathways Related to Aging and Frailty.

Aging and disease·2026
Same author

Identification of pre-frail/frail older adults using the Integrated Care for Older People WHO Step1 screening tool: a cross sectional study.

International journal of nursing studies advances·2026
Same author

Developing Topics.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025

Early diagnosis and comprehensive assessment are crucial for managing Alzheimer's disease (AD). Tailored treatment plans, including enhancing cholinergic function, can slow cognitive decline and improve patient and caregiver well-being.

Area of Science:

  • Neurology
  • Geriatrics
  • Public Health

Context:

  • Alzheimer's disease (AD) is a leading cause of progressive dementia, increasing patient dependence and healthcare burden.
  • Effective management necessitates early diagnosis and communication with patients and families.
  • Optimal Alzheimer's disease care requires a proactive, integrated approach.

Purpose:

  • To outline the essential components of early diagnosis and comprehensive assessment for Alzheimer's disease (AD) management.
  • To emphasize the importance of individualized treatment plans addressing medical, functional, cognitive, and behavioral aspects of AD.
  • To highlight the critical role of caregiver assessment and involvement in post-diagnostic care planning.

Summary:

  • Early Alzheimer's disease (AD) diagnosis and communication are foundational steps in management.

Related Experiment Videos

  • Enhancing cholinergic function can stabilize or slow cognitive decline in many AD patients.
  • Comprehensive assessment of patients, families, and home environments is vital for developing tailored treatment plans.
  • Assessment must include the patient's medical condition, functional and cognitive status, comorbidities, and behavioral symptoms.
  • Caregiver needs and risks must be evaluated, with their input actively sought for treatment planning.
  • Regular reassessment (every 6 months or as needed) ensures ongoing appropriateness of care.
  • Primary care practitioners should educate patients and families about the disease and collaboratively establish treatment goals.

    • Impact:

    • Facilitates timely intervention and personalized care strategies for Alzheimer's disease (AD) patients.
    • Empowers patients and families through education and shared decision-making in treatment planning.
    • Aims to improve quality of life and reduce the burden of Alzheimer's disease (AD) on individuals and the healthcare system.